In summary, we uncover that mitophagy/NRF2/SerpinG1 axis is fundamental for the macrophages-driven anti-septic AKI immunity and identify tubular SerpinG1 as a predictive marker for high-dose ascorbate efficacy. This evidence concerns the gene SERPING1 and acute kidney injury.